Liver cancer is one of the fastest rising forms of cancer in Canada. HCC is it’s most common form.
The key to reducing the incidences lies in prevention, early detection and intervention1.
In this program we feature from Dr. Jennifer Knox, Oncologist, Dr. Jordan Feld a Hepatologist and
Nem Maksimovic with the Canadian Liver Foundation. They share with us the impact of Stigma upon
liver disease as well as recent advances in treating HCC offering hope to patients with increased
options for therapy.
“I guess one way to define stigma in this case is an act of shaming or even treating someone differently
based on something like their health status.” (Nem Maksimovic, CLF)
Those at risk for liver disease or HCC should speak directly to their healthcare providers.
Financial sponsorship provided by Ipsen Canada
Dr. Jordan Feld
Hepatologist, Toronto General Hospital, Toronto Centre for Liver Disease
Professor of Medicine, University of Toronto
Dr. Jennifer Knox
Princess Margaret Cancer Cenre
Mr. Morteza Zokaei Ashtiani
Nem Maksimovic, MPH, MSc
Senior Manager, Support and Education,
Canadian Liver Foundation